Committee, Appointment of Audit Committee, Appointment of Company Secretary, the Establishment of New Subsidiary and Subsidiary to Purchase Drug Care Company Limited (Revise no. 2) 10/11/2021 09:27
Commission Notification of the Office of the Securities and Exchange Commission No. OrThor/Nor/Khor. 11/2548 Re: Practical Guideline on Application for Approval and Approval for Appointment of an Executive of
Office of the Securities and Exchange Commission No. OrThor/Nor/Khor. 11/2548 Re: Practical Guideline on Application for Approval and Approval for Appointment of an Executive of a Derivatives Business
and Exchange Commission Notification of the Office of the Securities and Exchange Commission No. OrThor/Nor/Khor. 11/2548 Re: Practical Guideline on Application for Approval and Approval for Appointment
Directors' Meeting No.8/2020, Appointment of Directors in Replacement of Those who will Retire by Rotation, and Addition of Agenda Items for the 2020 Annual General Meeting of Shareholders.(amended) 17/09
Directors Meeting No. 6/2018. 2. Approved the company’s performance and Financial Statement in the second quarter of 2018. 3. The meeting unanimously approved the appointment Mr. Yen, Ming-Shan to be Vice
:16 Notice of Notification of the Resolutions of the Board of Directors' Meeting No.2 /2022 regarding the appointment of director in replacement of director who resigned and to enter Connected
TorThor. 35/2556 Standard Conduct of Business, Management Arrangement, Operating Systems, and Providing Services to Clients of Securities Companies and Derivatives Intermediaries (Codefied) 06/09/2013 01
and Derivatives Business by Securities Company and Derivatives Intermediary 06/09/2013 01/04/2014 5. Notification of Capital Market Supervisory Board TorThor. 35/2556 Standard Conduct of Business
Business by Securities Company and Derivatives Intermediary 06/09/2013 01/04/2014 5. Notification of Capital Market Supervisory Board TorThor. 35/2556 Standard Conduct of Business, Management